Live Music Archive
Librivox Free Audio
Metropolitan Museum
Cleveland Museum of Art
Internet Arcade
Console Living Room
Books to Borrow
Open Library
TV News
Understanding 9/11
The National Institute of Health’s grant AI23946-08 issued to Dr. Ralph Baric at the University of North Carolina at
Chapel Hill (officially classified as affiliated with Dr. Anthony Fauci’s NIAID by at least 2003) began the work on
synthetically altering the Coronaviridae (the coronavirus family) for the express purpose of general research, pathogenic
enhancement, detection, manipulation, and potential therapeutic interventions targeting the same. As early as May 21,
2000, Dr. Baric and UNC sought to patent critical sections of the coronavirus family for their commercial benefit.1 In one
of the several papers derived from work sponsored by this grant, Dr. Baric published what he reported to be the full
the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV)
Baric filed an application for U.S. Patent 7,279,372 for a method of producing recombinant coronavirus. In the first
public record of the claims, they sought to patent a means of producing, “an infectious, replication defective,
coronavirus.” This work was supported by the NIH grant referenced above and GM63228. In short, the U.S. Department
of Health and Human Services was involved in the funding of amplifying the infectious nature of coronavirus between
This dossier is by no means exhaustive. It is, however, indicative the numerous criminal violations that may be
associated with the COVID-19 terrorism. All source materials are referenced herein. An additional detailed breakdown
of all the of individuals, research institutions, foundations, funding sources, and commercial enterprises can be accessed
upon request.
Chapel Hill (officially classified as affiliated with Dr. Anthony Fauci’s NIAID by at least 2003) began the work on
synthetically altering the Coronaviridae (the coronavirus family) for the express purpose of general research, pathogenic
enhancement, detection, manipulation, and potential therapeutic interventions targeting the same. As early as May 21,
2000, Dr. Baric and UNC sought to patent critical sections of the coronavirus family for their commercial benefit.1 In one
of the several papers derived from work sponsored by this grant, Dr. Baric published what he reported to be the full
length cDNA of SARS CoV in which it was clearly stated that SAR CoV was based on a composite of DNA segments.
“Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of
the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV)
that contained the expected marker mutations inserted into the component clones.”2
On April 19, 2002 – the Spring before the first SARS outbreak in Asia – Christopher M. Curtis, Boyd Yount, and Ralph
Baric filed an application for U.S. Patent 7,279,372 for a method of producing recombinant coronavirus. In the first
public record of the claims, they sought to patent a means of producing, “an infectious, replication defective,
coronavirus.” This work was supported by the NIH grant referenced above and GM63228. In short, the U.S. Department
of Health and Human Services was involved in the funding of amplifying the infectious nature of coronavirus between
1999 and 2002 before SARS was ever detected in humans.
This dossier is by no means exhaustive. It is, however, indicative the numerous criminal violations that may be
associated with the COVID-19 terrorism. All source materials are referenced herein. An additional detailed breakdown
of all the of individuals, research institutions, foundations, funding sources, and commercial enterprises can be accessed
upon request.
Reviews
There are no reviews yet. Be the first one to
write a review.
